Formulation Screening of Levetiracetam Sustained Release Tablets

Jing Zhou, Quanzhong Hu

Abstract


Objective: To prepare the sustained-release preparation of levetiracetam. Methods: The sustained-release materials were selected for wet granulation and tablet pressing, and the best formula was determined. Levetiracetam sustained-release tablets were prepared and the influencing factors were investigated. Results and Conclusions: The formulation was reasonable, the preparation process was simple, and the quality was stable.

Keywords


Levetiracetam; Sustained release tablets; Release; Stability

Full Text:

PDF

References


Levetiracetam sustained release tablets (trade name Keppra XR)® FDA instructions.

Import registration standard of levetiracetam tablets jx20070146.

Usp38 levetiracetam sustained release tablets.

Quality standard for clinical trial application of levetiracetam API.

Release determination method of levetiracetam sustained release tablets published by FDA.




DOI: https://doi.org/10.12346/jnp.v2i1.6278

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Jing Zhou, Quanzhong Hu

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.